How did MDXH's revenue and expenses trend in Q4 2024?

In Q4 2024, MDxHealth (MDXH) exhibited a notable improvement in gross margin, which increased by 5.85% to 61.23%. However, this positive trend was not reflected in the net income, which remained at -$6.84 million. The operating expenses were not provided, but the focus on improving gross margin suggests efforts to enhance operational efficiency and profitability.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|MDXH|MDXH.O|MDxHealth|20240101-2024|Licenses and royalties|139000|186|
|MDXH|MDXH.O|MDxHealth|20240101-2024|Licenses and royalties|30000|186|

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|MDXH|MDXH.O|MDxHealth|2024 Q1|27.31232385344607|-8511000|186|
|MDXH|MDXH.O|MDxHealth|2024 Q2|-8.488612836438923|-1.1528E7|186|
|MDXH|MDXH.O|MDxHealth|2024 Q3|-11.3887506222001|-1.1189E7|186|
|MDXH|MDXH.O|MDxHealth|2024 Q4|36.184701492537314|-6841000|186|

|code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code|
|---|---|---|---|---|---|---|
|MDXH|MDXH.O|MDxHealth|2024 Q1|60.8198|2.587639177744384|186|
|MDXH|MDXH.O|MDxHealth|2024 Q2|60.3648|1.479369519608375|186|
|MDXH|MDXH.O|MDxHealth|2024 Q3|60.6706|-1.408894724526139|186|
|MDXH|MDXH.O|MDxHealth|2024 Q4|61.2344|-2.1552109831392405|186|